浙江浙北药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
47
NMPA:47
Drug Approvals
Pregabalin Oral Solution
- Product Name
- 普瑞巴林口服溶液
- Approval Number
- 国药准字H20253751
- Approval Date
- Apr 1, 2025
NMPA
Metformin Hydrochloride and Glibenclamide Tablets(Ⅰ)
- Product Name
- 威能
- Approval Number
- 国药准字H20050510
- Approval Date
- Sep 3, 2024
NMPA
Fructose Sodium Diphosphate Oral Solution
- Product Name
- 果糖二磷酸钠口服溶液
- Approval Number
- 国药准字H20083454
- Approval Date
- Nov 14, 2022
NMPA
Sodium Ferulate for Injection
- Product Name
- 注射用阿魏酸钠
- Approval Number
- 国药准字H20067756
- Approval Date
- Feb 8, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found